论文信息 - Fixed Duration Therapy with Daratumumab, Carfilzomib, Lenalidomide and Dexamethasone for High Risk Smoldering Multiple Myeloma-Results of the Ascent Trial - 字舞流文

Fixed Duration Therapy with Daratumumab, Carfilzomib, Lenalidomide and Dexamethasone for High Risk Smoldering Multiple Myeloma-Results of the Ascent Trial

A. Jakubowiak | Shaji K. Kumar | B. Laplant | B. Durie | M. Bhutani | R. Abonour | A. Badros | B. Dhakal | M. Alsina | C. Rosenbaum | Al-Ola Abdallah | D. Egan | Erik J Asmus